Rescue of cardiac failing and remodelling by inhibition of protein phosphatase 1γ is associated with suppression of the alternative splicing factor-mediated splicing of Ca2+/calmodulin-dependent protein kinase δ

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 12, 2014, Pages 976-985

  Liao, Ru Jia ^a   Tong, Li Juan ^a   Huang, Chao ^a   Cao, Wen Wen ^a   Wang, Yu Zhe ^a   Wang, Jia ^a   Chen, Xiang Fan ^a   Zhu, Wei Zhong ^a   Zhang, Wei ^a  

^a NANTONG MEDICAL COLLEGE   (China)

Author keywords

Alternative splicing factor; Ca2+ calmodulin dependent protein kinase ; Cardiac hypertrophy; Inhibitor 1 of protein phosphatase 1; Protein phosphatase 1

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE DELTA; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 GAMMA; PHOSPHOPROTEIN PHOSPHATASE 1 INHIBITOR 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSFECTION; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RATE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WEIGHT; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

EID: 84912523545     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12308     Document Type: Article

References (40)

1. 2+ cycling in cardiac physiology and pathophysiology. Front. Biosci. (Landmark Ed) 2009; 14: 3571-85.
2. Qian J, Vafiadaki E, Florea SM et al. Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling. Circ. Res. 2011; 108: 1429-38.
3. Carr AN, Schmidt AG, Suzuki Y et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 2002; 22: 4124-35.
4. Bruchert N, Mavila N, Boknik P et al. Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. Am. J. Physiol. Heart Circ. Physiol. 2008; 295: H1539-46.
5. El-Armouche A, Wittkopper K, Degenhardt F et al. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc. Res. 2008; 80: 396-406.
6. Cohen PT. Two isoforms of protein phosphatase 1 may be produced from the same gene. FEBS Lett. 1988; 232: 17-23.
7. Dombradi V, Axton JM, Brewis ND, da Cruz e Silva EF, Alphey L, Cohen PT. Drosophila contains three genes that encode distinct isoforms of protein phosphatase 1. Eur. J. Biochem. 1990; 194: 739-45.
8. Sasaki K, Shima H, Kitagawa Y, Irino S, Sugimura T, Nagao M. Identification of members of the protein phosphatase 1 gene family in the rat and enhanced expression of protein phosphatase 1 alpha gene in rat hepatocellular carcinomas. Jpn. J. Cancer Res. 1990; 81: 1272-80.
9. Winding C, Sun Y, Hoger H et al. Serine/threonine-protein phosphatase 1 alpha levels are paralleling olfactory memory formation in the cd1 mouse. Electrophoresis 2011; 32: 1675-83.
10. 2+ cycling. Cardiovasc. Res. 2011; 89: 79-88.
11. Brown AM, Baucum AJ, Bass MA, Colbran RJ. Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a parkinson disease model. J. Biol. Chem. 2008; 283: 14286-94.
12. Trinkle-Mulcahy L, Andersen J, Lam YW, Moorhead G, Mann M, Lamond AI. Repo-Man recruits PP1 gamma to chromatin and is essential for cell viability. J. Cell Biol. 2006; 172: 679-92.
13. Chakrabarti R, Cheng L, Puri P, Soler D, Vijayaraghavan S. Protein phosphatase PP1 gamma 2 in sperm morphogenesis and epididymal initiation of sperm motility. Asian. J. Androl. 2007; 9: 445-52.
14. Vijayaraghavan S, Chakrabarti R, Myers K. Regulation of sperm function by protein phosphatase PP1gamma2. Soc. Reprod. Fertil. Suppl. 2007; 63: 111-21.
15. Sogawa K, Yamada T, Funamoto Y et al. Selective increase in expression of isoform PP1 gamma 1 of type-1 protein phosphatase in chondrosarcoma cells. Res. Commun. Mol. Pathol. Pharmacol. 1994; 86: 375-8.
16. Yamada T, Sogawa K, Masaki T et al. Enhanced expression of catalytic subunit isoform PP1 gamma 1 of protein phosphatase type 1 in malignant fibrous histiocytoma. Res. Commun. Mol. Pathol. Pharmacol. 1994; 86: 125-8.
17. Huang C, Cao WW, Liao RJ et al. PP1γ functionally augments the alternative splicing of CaMKIIδ through interaction with ASF. Am. J. Physiol. Cell Physiol. 2014; 306: C167-77.
18. 2+/calmodulin-dependent protein kinase isoforms. Biochim. Biophys. Acta 1994; 1221: 89-101.
19. 2+/calmodulin-dependent protein kinase II delta-subunit isoforms in rats with hypertensive cardiac hypertrophy. Mol. Cell. Biochem. 2001; 220: 69-76.
20. Srinivasan M, Edman CF, Schulman H. Alternative splicing introduces a nuclear localization signal that targets multifunctional cam kinase to the nucleus. J. Cell Biol. 1994; 126: 839-52.
21. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2a activity. J. Biol. Chem. 2002; 277: 1261-7.
22. Zhang T, Maier LS, Dalton ND et al. The deltac isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 2003; 92: 912-19.
23. Xu X, Yang D, Ding JH et al. ASF/SF2-regulated CaMKIIδ alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 2005; 120: 59-72.
24. Li C, Cai X, Sun H et al. The deltaa isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the hdac4-mef2 signaling pathway. Biochem. Biophys. Res. Commun. 2011; 409: 125-30.
25. Novoyatleva T, Heinrich B, Tang Y et al. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Hum. Mol. Genet. 2008; 17: 52-70.
26. Ma CT, Ghosh G, Fu XD, Adams JA. Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1. J. Mol. Biol. 2010; 403: 386-404.
27. Sumanasekera C, Kelemen O, Beullens M et al. C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1. Nucleic Acids Res. 2012; 40: 4025-39.
28. Huang C, Wang J, Chen Z, Wang Y, Zhang W. 2-Phenylethynesulfonamide prevents induction of pro-inflammatory factors and attenuates LPS-induced liver injury by targeting NHE1-Hsp70 complex in mice. PLoS ONE 2013; 8: e67582.
29. Huang C, Wang Y, Wang J, Yao W, Chen X, Zhang W. TSG (2, 3, 4', 5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia. J. Neuroinflammation 2013; 10:129.
30. Backs J, Backs T, Neef S et al. The delta isoform of CaMKII is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl. Acad. Sci. USA 2009; 106: 2342-7.
31. 2+ release. Circ. Res. 2003; 92: 904-11.
32. Maier LS. CaMKIIdelta overexpression in hypertrophy and heart failure: Cellular consequences for excitation-contraction coupling. Braz. J. Med. Biol. Res. 2005; 38: 1293-302.
33. Wang RH, Liu CW, Avramis VI, Berndt N. Protein phosphatase 1alpha-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 2001; 20: 6111-22.
34. Miyazaki Y, Ikeda Y, Shiraishi K et al. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling. PLoS ONE 2012; 7: e35875.
35. Wang R, Kaul A, Sperry AO. TLRR (lrrc67) interacts with PP1 and is associated with a cytoskeletal complex in the testis. Biol. Cell 2010; 102: 173-89.
36. Djouder N, Metzler SC, Schmidt A et al. S6k1-mediated disassembly of mitochondrial URI/PP1γ complexes activates a negative feedback program that counters S6k1 survival signaling. Mol. Cell 2007; 28: 28-40.
37. Peng W, Zhang Y, Zheng M et al. Cardioprotection by CaMKIIδB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ. Res. 2010; 106: 102-10.
38. Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP. Activation of CaMKIIδC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J. Biol. Chem. 2007; 282: 10833-9.
39. 2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ. Res. 2005; 97: 1009-17.
40. 2+/calmodulin kinase II. J. Clin. Invest. 2003; 111: 617-25.